GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Integra's (IART) strong focus on portfolio optimization and international expansion bolsters investors' confidence in the stock.
Integra (IART) reported earnings 30 days ago. What's next for the stock?
Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
Integra's (IART) Q4 revenues are impacted by the decline in the Tissue Technologies segment.
The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Integra LifeSciences (IART) came out with quarterly earnings of $0.89 per share, missing the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.94 per share a year ago.
Besides Wall Street's top -and-bottom-line estimates for Integra (IART), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 202
Investors remain optimistic about Integra (IART) due to the positive outlook for its CSS segment.
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president
Integra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition.
Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2023 Earnings Call October 25, 2023 8:30 AM ET Company Participants Chris Ward - Senior Director of Investor Relations Jan De Witte - Presid
Integra LifeSciences (IART) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.86 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE